It is evident indeed that an increased miR-146a expression is present in the lesional skin of AD patients [104], as it inhibits nuclear factor κ B (NF-κB)-mediated proinflammatory cytokines and chemokines, bringing alleviation of the inflammation directly linked to AD and similar conditions [91]. This evidence concerns the gene NFKB1 and Alzheimer disease.